The ACCC has raised a number of preliminary concerns about Chemist Warehouse’s $8 billion reverse merger into Sigma Healthcare. But dealmakers involved insist they were bracing for worse.
Deals
It’s the most watched and perhaps most polarising IPO on the ASX in years but Guzman y Gomez's investors are happy to pay a premium for a local growth story.
After a painfully slow 12 months, dealmakers expect their fortunes are finally turning around as markets shake out.
Analysts believe the Australian miner can still secure its target if it is willing to compensate shareholders for the risk of asset disposals.
